Zdrowie i gospodarka · 02/08/2016
FDA Clears Way for Tolvaptan Tablets Approval
The US Food and Drug Administration has ruled that the 60mg SAMSCA (tolvaptan) tablets were not withdrawn from sale due to safety or efficacy concerns, paving the way for potential approval of abbreviated new drug applications for the medication.